SCHEMBL30587159

SCHEMBL30587159

O=C(Nc1ccc(-c2nnc(-c3ccccc3)o2)cc1)c1cccnn1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMO Q99835 1/20 0.63
HSD17B10 Q99714 5/20 0.58
TSHR P16473 3/20 0.58
USP2 O75604 1/20 0.58
MAPK1 P28482 1/20 0.58
RAB9A P51151 6/20 0.56
KMT2A Q03164 6/20 0.56
NPC1 O15118 5/20 0.56
MEN1 O00255 4/20 0.56
TP53 P04637 1/20 0.56
POLB P06746 1/20 0.56
ALDH1A1 P00352 6/20 0.55
HPGD P15428 4/20 0.55
SMN1; SMN2 Q16637 2/20 0.55
HDAC6 Q9UBN7 1/20 0.51
AHR P35869 1/20 0.51
KDM4E B2RXH2 6/20 0.49
LMNA P02545 1/20 0.49
PTGS2 P35354 2/20 0.49
HTT P42858 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24474003 1.00 SMO (0.63) SMOHSD17B10TSHRUSP2MAPK1
SCHEMBL31025870 0.83 AHR (0.69) RAB9AKMT2ANPC1MEN1POLB
SCHEMBL30587146 0.81 SMO (0.65) SMOHSD17B10TSHRUSP2MAPK1
SCHEMBL24474056 0.81 SMO (0.65) SMOHSD17B10TSHRUSP2MAPK1
SCHEMBL8770855 0.79 NPC1 (0.74) SMOHSD17B10TSHRUSP2MAPK1
SCHEMBL24474001 0.78 SMN1; SMN2 (0.67) SMOHSD17B10TSHRUSP2MAPK1
SCHEMBL24473983 0.78 NPC1 (0.61) SMOHSD17B10TSHRUSP2MAPK1
SCHEMBL30587155 0.78 NPC1 (0.61) SMOHSD17B10TSHRUSP2MAPK1
SCHEMBL24474006 0.78 SMO (0.65) SMOHSD17B10TSHRUSP2MAPK1
SCHEMBL16384061 0.77 SMO (1.00) SMOHSD17B10TSHRUSP2MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116457353-A N-substituted 4- (5-phenyl-1, 3, 4-oxadiazol-2-yl) anilines for the treatment and prophylaxis of hepatitis b virus infections 豪夫迈·罗氏有限公司 2023-07-18 CN disclosed